We found that loss of IL-6 resulted in reduced levels of multiple serum cytokines and chemokines that are part of the JAK-STAT3 signalling pathway and a reduction in tumour incidence; and where there were sufficient tumours to analyse, mice with loss of IL-6 showed reduced spread to other organs. This evidence concerns the gene IL6 and neoplasm.